Evidence map›Paper›PMID 23564309›Full record

ArticleJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract2013

Adenocarcinoma of the esophagus in the young.

Arzu Oezcelik, Shahin Ayazi, Steven R DeMeester, Joerg Zehetner, Emmanuele Abate, Joie Dunn, Kimberly S Grant, John C Lipham, Jeffrey A Hagen, Tom R DeMeester

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Is the age of diagnosis of esophageal adenocarcinoma getting younger? Analysis at a tertiary care center.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2020
    Article
  5. Article
  6. Article
  7. Young Adult Cancer: Influence of the Obesity Pandemic.Obesity (Silver Spring, Md.) · 2018
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Face Barrett's: esophageal adenocarcinoma affects the young.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2014
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Arzu OezcelikDivision of Thoracic Foregut Surgery, Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Shahin Ayazi
Steven R DeMeester
Joerg Zehetner
Emmanuele Abate
Joie Dunn
Kimberly S Grant
John C Lipham
Jeffrey A Hagen
Tom R DeMeester

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPractitioners have noted a striking increase in the number of young patients under the age of 40 years old who develop esophageal adenocarcinoma. The aim of this study was to characterize the presentation, pathology and therapeutic outcome of these young patients.

methodsThe records of patients who presented to the Foregut Surgical Service at the University of Southern California with esophageal adenocarcinoma between 2000 and 2007 were retrospectively reviewed. The presentation, tumor stage and histology, therapy and outcome of the patients under the age of 40 were compared to those ≥40.

resultsOf the 374 patients reviewed, 20 (5 %) were under the age of 40. There were two patients in their second and 18 in their third decade of life. The youngest patient was 25 years old. A history of gastroesophageal reflux disease or Barrett's esophagus was less common in patients <40 than in those ≥40; 15 and 5 % compared to 61 and 46 %. Similarly, patients <40 had a significantly longer time interval between the onset of symptoms and the diagnosis of their cancer than those ≥40; 4.5 vs. 2 months, p = 0.04. They also had a higher prevalence of stage IV disease (30 vs. 6 %, p = 0.0003), a shorter time to recurrence (9.5 vs.19 month, p = 0.002), and a poorer median survival (17 vs. 43 month, p = 0.04).

conclusionEsophageal adenocarcinoma in patients <40 years old commonly presents with an advanced stage of the disease and an associated poor survival. This is likely due to a low index of suspicion that dysphagia seen in younger patients is due to a malignancy.

Indexed as

AdenocarcinomaAdultAgedBarrett EsophagusDeglutition DisordersDisease-Free SurvivalEsophageal NeoplasmsEsophagectomyFemaleGastroesophageal RefluxHumansMaleMiddle AgedNeoplasm Recurrence, LocalNeoplasm StagingRetrospective Studies

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.